[{"address1": "7171 Frederick-Banting, Building 2", "address2": "Suite 270 St-Laurent", "city": "Montreal", "state": "QC", "zip": "H4S 1Z9", "country": "Canada", "phone": "857-412-7018", "website": "https://www.reparerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase that is in Phase 1/2 clinical trial for the treatment of solid tumors; and lunresertib (RP-6306), a selective and potent oral small molecule inhibitor of Protein Kinase Membrane-associated tyrosine-and threonine-specific cdc-2 inhibitory kinase that is in Phase 1/2 clinical trial. In addition, the company is developing RP-1664, an oral PLK4 inhibitor in Phase 1 clinical trial to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, an inhibitor of adenosinetriphosphatase activity on the helicase domain of DNA polymerase theta that is in Phase 1 clinical trial. The company has strategic collaborations with Hoffmann-La Roche Inc., F. HoffmannLa Roche Ltd, Debiopharm International S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Company Ltd., and New York University. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.", "fullTimeEmployees": 129, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Zinda Ph.D.", "age": 53, "title": "Executive VP & Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 661153, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Forte CPA", "age": 45, "title": "President, CFO, CEO & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 631996, "exercisedValue": 0, "unexercisedValue": 1765836}, {"maxAge": 1, "name": "Dr. Daniel  Durocher Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank  Sicheri Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Agnel  Sfeir Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra  Alves", "age": 45, "title": "Senior VP & Chief Accounting Officer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Belanger", "title": "Executive Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph P. O'Connell M.D.", "age": 70, "title": "Executive Vice President of Clinical Development and Medical Affairs", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.66, "open": 1.68, "dayLow": 1.63, "dayHigh": 1.68, "regularMarketPreviousClose": 1.66, "regularMarketOpen": 1.68, "regularMarketDayLow": 1.63, "regularMarketDayHigh": 1.68, "payoutRatio": 0.0, "beta": 0.926, "forwardPE": -0.56228954, "volume": 48753, "regularMarketVolume": 48753, "averageVolume": 287560, "averageVolume10days": 89020, "averageDailyVolume10Day": 89020, "bid": 1.19, "ask": 2.13, "bidSize": 2, "askSize": 2, "marketCap": 71741864, "fiftyTwoWeekLow": 0.89, "fiftyTwoWeekHigh": 4.069, "priceToSalesTrailing12Months": 286.96747, "fiftyDayAverage": 1.519, "twoHundredDayAverage": 1.54518, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -37081184, "profitMargins": 0.0, "floatShares": 22715092, "sharesOutstanding": 42959200, "sharesShort": 634153, "sharesShortPriorMonth": 561427, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0148, "heldPercentInsiders": 0.01248, "heldPercentInstitutions": 0.64944, "shortRatio": 1.06, "shortPercentOfFloat": 0.0217, "impliedSharesOutstanding": 42959200, "bookValue": 2.57, "priceToBook": 0.6498054, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -109864000, "trailingEps": -2.58, "forwardEps": -2.97, "enterpriseToRevenue": -148.325, "enterpriseToEbitda": 0.336, "52WeekChange": -0.40569395, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 1.67, "targetHighPrice": 5.0, "targetLowPrice": 5.0, "targetMeanPrice": 5.0, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 109472000, "totalCashPerShare": 2.548, "ebitda": -110471000, "totalDebt": 649000, "quickRatio": 6.178, "currentRatio": 6.302, "totalRevenue": 250000, "debtToEquity": 0.588, "revenuePerShare": 0.006, "returnOnAssets": -0.38824, "returnOnEquity": -0.69958, "grossProfits": 15364000, "freeCashflow": -57422624, "operatingCashflow": -103338000, "revenueGrowth": -0.767, "grossMargins": 61.456, "ebitdaMargins": 0.0, "operatingMargins": -80.248, "financialCurrency": "USD", "symbol": "RPTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 0.602409, "regularMarketPrice": 1.67, "corporateActions": [], "postMarketTime": 1756497843, "regularMarketTime": 1756497600, "exchange": "NMS", "messageBoardId": "finmb_435208167", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1592573400000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.67, "postMarketChange": 0.0, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.63 - 1.68", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 287560, "fiftyTwoWeekLowChange": 0.78, "fiftyTwoWeekLowChangePercent": 0.87640446, "fiftyTwoWeekRange": "0.89 - 4.069", "fiftyTwoWeekHighChange": -2.3989997, "fiftyTwoWeekHighChangePercent": -0.5895797, "fiftyTwoWeekChangePercent": -40.569393, "earningsTimestamp": 1754656200, "earningsTimestampStart": 1762432200, "earningsTimestampEnd": 1762432200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.58, "epsForward": -2.97, "epsCurrentYear": -2.11, "priceEpsCurrentYear": -0.7914692, "fiftyDayAverageChange": 0.1509999, "fiftyDayAverageChangePercent": 0.099407434, "twoHundredDayAverageChange": 0.124819994, "twoHundredDayAverageChangePercent": 0.08078023, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-19", "cryptoTradeable": false, "longName": "Repare Therapeutics Inc.", "shortName": "Repare Therapeutics Inc.", "displayName": "Repare Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]